Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach
Smith, Roger A, Barbosa, James, Blum, Cheri L, Bobko, Mark A, Caringal, Yolanda V, Dally, Robert, Johnson, Jeffrey S, Katz, Michael E, Kennure, Nancy, Kingery-Wood, Jill, Lee, Wendy, Lowinger, Timothy B, Lyons, John, Marsh, Vivienne, Rogers, Daniel H, Swartz, Stephen, Walling, Tracy, Wild, Hanno
Published in Bioorganic & medicinal chemistry letters (22.10.2001)
Published in Bioorganic & medicinal chemistry letters (22.10.2001)
Get full text
Journal Article
The importance of chemistry for the future of the pharma industry
Wild, Hanno, Heimbach, Dirk, Huwe, Christoph
Published in Angewandte Chemie International Edition (08.08.2011)
Published in Angewandte Chemie International Edition (08.08.2011)
Get full text
Journal Article
"Collaborative Innovation"-Regaining the Edge in Drug Discovery
Wild, Hanno, Huwe, Christoph, Lessl, Monika
Published in Angewandte Chemie (International ed.) (04.03.2013)
Published in Angewandte Chemie (International ed.) (04.03.2013)
Get full text
Journal Article
Editorial: The Importance of Chemistry for the Future of the Pharma Industry
Wild, Hanno, Heimbach, Dirk, Huwe, Christoph
Published in Angewandte Chemie (International ed.) (08.08.2011)
Published in Angewandte Chemie (International ed.) (08.08.2011)
Get full text
Journal Article
Abstract 849: Synergistic effect of MSLN-TTC in combination with DNA damage response inhibitors
Wickstroem, Katrine, Hagemann, Urs B., Wengner, Antje M., Kristian, Alexander, Ellingsen, Christine, Siemeister, Gerhard, Bjerke, Roger M., Karlsson, Jenny, Ryan, Olav B., Linden, Lars, Kreft, Bertolt, Mumberg, Dominik, Wild, Hanno, Ziegelbauer, Karl, Cuthbertson, Alan
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 855: Increased in vitro potency and in vivo efficacy of FGFR2-targeted thorium-227 conjugate (FGFR2-TTC) in combination with the ATR inhibitor BAY 1895344
Wickstroem, Katrine, Hagemann, Urs B., Wengner, Antje M., Sommer, Anette, Kristian, Alexander, Ellingsen, Christine, Bjerke, Roger M., Karlsson, Jenny, Ryan, Olav B., Linden, Lars, Kreft, Bertolt, Mumberg, Dominik, Wild, Hanno, Ziegelbauer, Karl, Cuthbertson, Alan
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 850: Mesothelin targeted thorium-227 conjugate (MSLN-TTC): Preclinical evaluation of a new targeted alpha therapeutic in mesothelin-positive cancers
Hagemann, Urs B., Kristian, Alexander, Ellingsen, Christine, Wickstroem, Katrine, Mobergslien, Anne, Karlsson, Jenny, Bjerke, Roger M., Schatz, Christoph, Kneip, Christoph, Schuhmacher, Joachim, Oedegaardstuen, Liv-Ingrid, Hennekes, Hartwig, Tafuri, Anna, Mumberg, Dominik, Wild, Hanno, Ziegelbauer, Karl, Cuthbertson, Alan S.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 5199: Preclinical activity of the FGFR2-targeted thorium-227 conjugate in preclinical models of colorectal, gastric and triple-negative breast cancer
Hagemann, Urs B., Sommer, Anette, Kristian, Alexander, Wang, Ellen, Larsen, Åsmund, Wirnitzer, Uta, Ellinger-Ziegelbauer, Heidrun, Sandmann, Steffen, Poethko, Thorsten, Karlsson, Jenny, Bjerke, Roger M., Linden, Lars, Kreft, Bertolt, Wild, Hanno, Cuthbertson, Alan S.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, Tobias, Hendrix, Martin, Hillisch, Alexander, Lobell, Mario, Meier, Heinrich, Schmeck, Carsten, Wild, Hanno, Hinzen, Berthold
Published in Drug discovery today (01.02.2006)
Published in Drug discovery today (01.02.2006)
Get full text
Journal Article
One target – multiple indications: a call for an integrated common mechanisms strategy
Nielsch, Ulrich, Schäfer, Stefan, Wild, Hanno, Busch, Andreas
Published in Drug discovery today (01.12.2007)
Published in Drug discovery today (01.12.2007)
Get full text
Journal Article
SUBSTITUTED DIPYRIDYL-DIHYDROPYRAZOLONES AND USE THEREOF
JESKE MARIO, FLAMME INGO, OEHME FELIX, ERGUEDEN JENS KERIM, BECK HARTMUT, THEDE KAI, KOLKHOF PETER, STOLL FRIEDERIKE, WILD HANNO
Year of Publication 27.07.2009
Get full text
Year of Publication 27.07.2009
Patent
SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HAEMATOLOGICAL DISEASES
JESKE MARIO, SCHUHMACHER JOACHIM, FLAMME INGO, OEHME FELIX, AKBABA METIN, ERGUEDEN JENS KERIM, BECK HARTMUT, THEDE KAI, KELDENICH JOERG, KOLKHOF PETER, STOLL FRIEDERIKE, WILD HANNO
Year of Publication 07.07.2009
Get full text
Year of Publication 07.07.2009
Patent
p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas
Redman, Anikó M, Johnson, Jeffrey S, Dally, Robert, Swartz, Steve, Wild, Hanno, Paulsen, Holger, Caringal, Yolanda, Gunn, David, Renick, Joel, Osterhout, Martin, Kingery-Wood, Jill, Smith, Roger A, Lee, Wendy, Dumas, Jacques, Wilhelm, Scott M, Housley, Timothy J, Bhargava, Ajay, Ranges, Gerald E, Shrikhande, Alka, Young, Deborah, Bombara, Michael, Scott, William J
Published in Bioorganic & medicinal chemistry letters (08.01.2001)
Published in Bioorganic & medicinal chemistry letters (08.01.2001)
Get full text
Journal Article
di-hidropirazolonas substituídas, seus usos e seu processo de preparação, e medicamento
HARTMUT BECK, PETER KOLKHOF, Ingo Flamme, JÖRG KELDENICH, Felix Oehme, Jens-Kerim Ergüden, Joachim Schuhmacher, Kai Thede, Mario Jeske, FRIEDERIKE STOLL, Hanno Wild, METIN AKBABA
Year of Publication 25.05.2021
Get full text
Year of Publication 25.05.2021
Patent